Software & Data
Overall Rank: 275
Category: Software & Data
Category Rank: 51
- Top HealthTech Company of 2022
Clinical ink is the global life science company that brings data, technology, and patient science together. Their deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials.
Founded in 2007 by Doug Pierce and Dr. Tommy LittleJohn, Clinical ink offered the first purpose-built solution to directly digitize clinical trial source data, eSource. Since then, the company has expanded its reach and clinical trial solution portfolio to lead the industry, which is increasingly embracing mobile technologies, virtual studies, and decentralized clinical trials. With over 293% growth between 2020 and 2021 alone, Clinical ink was listed on 2021’s Deloitte Technology Fast 500, as well as nominated as Technology Company of the Year by the Philadelphia Alliance for Capital and Technologies (PACT), which celebrates the achievement and innovation of life sciences leaders. By harnessing digital data, Clinical ink powers sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.
eCOA (ePRO, eClinRo,eObsRO)
With the Clinical ink platform, make data collection and analysis easier: realize improved clinical trial efficiency, quality, and safety, have real-time data access and review, and eliminate data errors.
eConsent can help you address many difficulties by raising patient comprehension, easing workloads for study teams and sites, and improving data quality to support confident decision-making and regulatory compliance.
Direct Data Capture (DDC)
Instant data, increased compliance, and more effective oversight is a departure from how trials have historically processed disparate data. Custom DDC designs improve clinical trial execution, produce cleaner data, and help ensure that documentation complies with regulations.
eLAS® has set the standard for data collection in Lupus research with its unique integration of the most often used diagnostic questionnaires (BILAG, SLEDAI, CLASI), intuitive interface, and ability to display data from previous visits, eLAS® is designed to be used during the patient visit. When the visit is complete, so is the documentation.